Central Garden & Pet Company (NASDAQ:CENTA) to Announce Q4 and Fiscal 2025 Results
Central Garden & Pet Company (NASDAQ:CENTA), a key player in the pet and garden industries, will release its fourth quarter and fiscal year 2025 financial results on November 24, 2025. The announcement will cover the financial period ending September 27, 2025.
Wall Street estimates project an earnings per share (EPS) of -$0.20. This figure is aligned with the Zacks Consensus Estimate, which also forecasts a quarterly loss of $0.20 per share. Revenue for the quarter is expected to be approximately $657.86 million.
The company's current financial health is reflected in several key metrics. The price-to-earnings (P/E) ratio is approximately 12.32, while the price-to-sales ratio is about 0.57. The enterprise value to sales ratio for Central Garden & Pet is 0.80.
In terms of liquidity and debt, the company shows a strong position with a current ratio of 3.56. A debt-to-equity ratio of 0.90 suggests a moderate level of debt compared to its equity.
An earnings call led by CEO Niko Lahanas and CFO Brad Smith will follow the release. The management team's discussion on business conditions will offer insights into the company's strategy, mission, and vision. Further details can be found in the company's history and ownership information and its investor profile.
Central Garden & Pet Company (CENTA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.